How to Get Fosamax (Alendronate) in Maryland

What Is Alendronate and Why Is It Prescribed?

Alendronate belongs to the bisphosphonate drug class. It works by binding to hydroxyapatite in bone and inhibiting osteoclast-mediated bone resorption, which slows the rate of bone loss and allows bone-forming cells to rebuild density over time. The FDA approved Fosamax (Merck's brand) in 1995 for postmenopausal osteoporosis, and the indication later expanded to include glucocorticoid-induced osteoporosis, male osteoporosis, and Paget's disease of bone 1.

The Fracture Intervention Trial (FIT), published in JAMA in 1998 with 2,027 women who had at least one vertebral fracture at baseline, demonstrated that alendronate 5 to 10 mg daily reduced the risk of new vertebral fractures by 47% and hip fractures by 51% over a mean follow-up of 2.9 years 2. A subsequent extension study showed that women who continued alendronate for 10 years maintained bone mineral density (BMD) gains, while those switched to placebo after 5 years experienced modest but measurable BMD decline at the hip 3.

These results shaped every major guideline that followed. The Endocrine Society's 2019 clinical practice guideline on pharmacologic management of osteoporosis in postmenopausal women lists oral alendronate as a first-line therapy for patients at moderate fracture risk.

Step-by-Step: Getting an Alendronate Prescription in Maryland

The process is straightforward. You need a prescriber, a bone density assessment, a few labs, and a pharmacy. Here is how each step works for Maryland residents.

1. See a prescriber. Maryland law permits physicians (MD or DO), certified registered nurse practitioners (CRNPs), and physician assistants (PAs) to prescribe alendronate. You do not need a specialist referral. Primary care providers write the majority of bisphosphonate prescriptions nationally. According to AAFP guidance, screening with DEXA is recommended for all women aged 65 and older and for younger postmenopausal women with clinical risk factors.

2. Get a DEXA scan. A dual-energy X-ray absorptiometry (DEXA) scan at the hip and lumbar spine establishes your T-score. The WHO defines osteoporosis as a T-score of −2.5 or lower and osteopenia as a T-score between −1.0 and −2.5 4. Maryland imaging centers typically provide same-week DEXA appointments. Many health systems in the Baltimore, Silver Spring, and Annapolis corridors offer walk-in bone density screening.

3. Complete baseline labs. Before starting alendronate, your provider will likely order serum calcium, 25-hydroxyvitamin D, a basic metabolic panel (to check renal function), and sometimes a serum alkaline phosphatase. Patients with a glomerular filtration rate (GFR) below 35 mL/min should not take alendronate per the FDA label [1].

4. Fill the prescription. Generic alendronate 70 mg weekly tablets are stocked at virtually every retail pharmacy in Maryland, including CVS, Walgreens, Giant, Rite Aid, and independent pharmacies. Cash prices for a 30-day supply of generic alendronate range from $4 to $15. Brand-name Fosamax is rarely dispensed today because the generic bioequivalent is FDA-approved and significantly cheaper.

Telehealth Access to Fosamax in Maryland

Maryland fully permits telehealth prescribing for alendronate. Good news for residents in rural Western Maryland or the Eastern Shore who may live far from a bone health specialist. The Maryland Board of Physicians requires that telehealth providers hold an active Maryland medical license or a qualifying interstate compact license 5.

A telehealth visit for osteoporosis management typically takes 15 to 25 minutes. Your provider will review your DEXA results, lab work, fracture history, and risk factors. If alendronate is appropriate, they can electronically prescribe the medication to any Maryland pharmacy.

One practical consideration: DEXA scans still require an in-person visit. Telehealth can handle the clinical evaluation, prescribing, and follow-up monitoring, but you will need to visit an imaging center for the scan itself. Several Maryland health systems now offer a "hybrid" workflow where the DEXA is done at a local imaging center and results are forwarded to the telehealth provider for review.

The U.S. Preventive Services Task Force (USPSTF) gives osteoporosis screening in women 65 and older a Grade B recommendation, which means most insurers are required to cover the DEXA scan with no out-of-pocket cost under the Affordable Care Act's preventive services mandate [6].

Maryland Medicaid and Insurance Coverage

Maryland Medicaid covers alendronate with prior authorization (PA). The PA process exists because Medicaid formularies require documentation that the drug is medically necessary. In practice, PA for alendronate is rarely denied when the prescriber submits a DEXA T-score of −2.5 or lower, or a T-score between −1.0 and −2.5 with a FRAX 10-year major osteoporotic fracture probability exceeding 20%.

What the PA submission requires:

• Patient demographics and Medicaid ID
• DEXA scan results with T-scores at the hip and/or lumbar spine
• Relevant lab work (calcium, vitamin D, renal function)
• A brief clinical note documenting osteoporosis diagnosis or high fracture risk
• Prior medication trials, if applicable (some Medicaid managed care organizations may ask whether calcium and vitamin D supplementation were tried first)

PA turnaround in Maryland is typically 24 to 72 hours for standard requests and 24 hours for urgent requests.

Commercial insurance plans in Maryland, including CareFirst BlueCross BlueShield, Aetna, Cigna, and UnitedHealthcare, almost universally cover generic alendronate at Tier 1 or Tier 2 copays. A 2020 analysis in the Journal of Managed Care & Specialty Pharmacy found that patient out-of-pocket costs for generic oral bisphosphonates averaged $6.40 per month across commercial plans 7.

Medicare Part D also covers generic alendronate. Under the Inflation Reduction Act's $2,000 annual out-of-pocket cap (effective 2025), alendronate costs for Medicare beneficiaries are minimal. Most Part D plans place generic alendronate in Tier 1 with copays of $0 to $10.

503A Compounding Pharmacies in Maryland

Maryland licenses 503A compounding pharmacies that can prepare alendronate in alternative formulations if clinically needed. This option is uncommon for alendronate because the commercially available 70 mg tablet is effective, inexpensive, and well tolerated by most patients. A compounded version might be appropriate for patients who cannot swallow standard tablets and need a liquid preparation.

503A pharmacies in Maryland must comply with USP Chapter 795 standards and hold a valid Maryland Board of Pharmacy compounding permit. Compounded drugs are not FDA-approved, so insurance coverage is typically not available for compounded alendronate. Patients should expect to pay out of pocket, with costs ranging from $25 to $60 per month depending on the formulation and pharmacy.

How to Take Alendronate Correctly

Proper administration matters more with alendronate than with most oral medications. The drug has very low oral bioavailability (0.64% under fasting conditions), and food, beverages other than plain water, and even certain supplements can reduce absorption to near zero 1.

The FDA label specifies these instructions:

• Take alendronate first thing in the morning, at least 30 minutes before any food, drink, or other medication.
• Swallow the tablet with 6 to 8 ounces of plain water only. Do not use coffee, juice, or mineral water.
• Do not lie down for at least 30 minutes after taking the tablet. Remain upright (sitting or standing) to reduce esophageal irritation risk.
• Do not chew or crush the tablet.

Dr. Ethel Siris, a professor of medicine at Columbia University Medical Center and co-author of the FIT extension study, has noted: "Adherence to the dosing instructions is as important as taking the drug itself. Patients who take alendronate with coffee or lie down afterward are both reducing the drug's effectiveness and increasing the risk of esophageal side effects" 8.

The 2020 American Association of Clinical Endocrinology (AACE) clinical practice guidelines for osteoporosis state: "Oral bisphosphonates should be considered first-line therapy for most patients with osteoporosis who do not have contraindications such as esophageal disorders or significant renal impairment" 9.

Side Effects and Monitoring

Most patients tolerate alendronate well. The FIT trial reported that adverse event rates were similar between the alendronate and placebo groups for most categories 2. The most common side effects are gastrointestinal: heartburn, nausea, abdominal pain, and esophageal irritation.

Rare but serious risks include:

• Osteonecrosis of the jaw (ONJ). Exceedingly rare with oral bisphosphonates. A 2015 systematic review published in the Journal of Bone and Mineral Research estimated the incidence at 1 per 10,000 to 1 per 100,000 patient-years for oral bisphosphonate users 10.
• Atypical femoral fractures (AFF). Associated with long-term use beyond 5 years. The absolute risk remains low: approximately 3.2 to 50 cases per 100,000 person-years depending on duration of use, according to a 2020 meta-analysis in the Journal of Bone and Mineral Research 11.
• Esophageal ulceration. Occurs primarily when dosing instructions are not followed.

Monitoring schedule in Maryland:

• DEXA scan at baseline and typically repeated at 2 years to assess treatment response. The AACE guidelines recommend repeating DEXA every 1 to 2 years during initial treatment [9].
• Serum calcium and vitamin D should be checked annually.
• Renal function should be reassessed if clinical status changes.
• After 5 years of continuous use, your provider should discuss a "bisphosphonate holiday." The FLEX trial extension showed that women who discontinued alendronate after 5 years maintained fracture risk reduction for vertebral fractures, though hip BMD declined modestly 3.

Transferring a Fosamax Prescription to Maryland

If you are moving to Maryland from another state, your existing alendronate prescription can be transferred. Maryland pharmacies accept prescription transfers from other states under the Maryland Board of Pharmacy's reciprocal transfer rules. The process works as follows:

Call your new Maryland pharmacy and provide the name and phone number of your previous pharmacy. The receiving pharmacist will contact the originating pharmacy to verify and transfer the prescription. If your prescription has no remaining refills, you will need a new prescription from a Maryland-licensed provider.

For patients switching from a provider in another state, a single telehealth visit with a Maryland-licensed prescriber is often the fastest way to establish care and get a new prescription. Bring your most recent DEXA scan results and lab work to avoid repeating tests.

Timeline: How Long Until You Receive Alendronate in Maryland?

The typical timeline from initial contact to taking your first dose:

• Day 1: Schedule a visit (in-person or telehealth) with a Maryland-licensed prescriber.
• Days 1 to 5: Complete DEXA scan if you do not have recent results (within the past 2 years).
• Days 1 to 3: Baseline labs drawn and resulted.
• Day of visit: Provider reviews results, prescribes alendronate, and sends the electronic prescription to your pharmacy.
• Same day or next day: Pick up alendronate at your pharmacy. Generic alendronate is almost always in stock.

For patients with commercial insurance and no prior authorization requirement, the process can be completed in as little as 2 to 3 days. For Maryland Medicaid patients, add 1 to 3 days for PA processing. Total time from first appointment to first dose: 2 to 7 days in most cases.